Relation of serum sialic acid with serum lipids in cardiac patients

Inayat-ur-Rahman1, S A Malik, Wilayat Ahmad Khan

  • 1Institute of Paramedical Technologies, Gandhara Technologies, Gandhara University, Peshawar.

Insights

Elevated serum sialic acid levels are linked to coronary heart disease risk. This study found higher sialic acid and altered lipid profiles in cardiac patients, indicating its role in cardiovascular complications.

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Chemistry

Background:

  • Elevated serum sialic acid is a known risk factor for coronary heart disease (CHD).
  • Dyslipidemia often coexists with increased CHD risk.
  • Understanding the relationship between sialic acid and lipid profiles in cardiac patients is crucial.

Purpose of the Study:

  • To investigate serum sialic acid concentrations and lipid profiles in cardiac patients.
  • To compare these levels with healthy control groups.
  • To explore the implications of altered sialic acid levels in cardiovascular complications.

Main Methods:

  • Serum sialic acid and lipid profiles (including HDL-C) were measured.
  • Healthy subjects were divided into two groups (A1, A2).
  • Cardiac patients were divided into male (Group B) and female (Group C) groups.

Main Results:

  • A significant increase in serum sialic acid was observed in all cardiac patient groups compared to controls.
  • Most lipid profile variables, except HDL-C, were significantly elevated in patients.
  • HDL-C levels showed a significant decrease in cardiac patients.

Conclusions:

  • Increased serum sialic acid levels are strongly associated with cardiac patients.
  • The findings suggest a role for elevated sialic acid in the development of cardiovascular complications.
  • Sialic acid may serve as a potential biomarker for cardiovascular risk assessment.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...